|
|
||||||||
Clinical Chemistry, Vol 39, 648-652, Copyright © 1993 by American Association for Clinical Chemistry
SB Rosalki, AY Foo, A Burlina, W Prellwitz, P Stieber, D Neumeier, G Klein, WA Poppe and H Bodenmuller
Royal Free Hospital and School of Medicine, London, UK.
A test kit (Iso-ALP, Boehringer Mannheim) for measuring human bone alkaline phosphatase activity in serum or plasma was evaluated in five laboratories in three countries. The assay is based on the principle described by Rosalki and Foo (Clin Chem 1984;30:1182-6) and uses wheat germ lectin to precipitate bone alkaline phosphatase. Residual ALP in the supernate in comparison with total ALP is used to quantify the bone fraction. The imprecision of residual ALP measurement was low (median between-run CV 4.9%) and comparable with that of total ALP. Linearity of precipitation was demonstrable up to a bone ALP activity (diethanolamine buffer 37 degrees C) of 2000 U/L, though a matrix effect was observed for dilutions of high-activity sera in saline or bovine serum albumin. For assaying patients' samples, different batches of lectin demonstrated excellent comparability. Taking electrophoresis as a basis for standardization, we determined that the lectin precipitated approximately 90% of bone ALP, but < 5% of nonbone ALP. From this we derived serum/plasma upper reference limits for bone ALP activity in adults and children.
The following articles in journals at HighWire Press have cited this article:
![]() |
C. Parkinson, M. Kassem, L. Heickendorff, A. Flyvbjerg, and P. J. Trainer Pegvisomant-Induced Serum Insulin-Like Growth Factor-I Normalization in Patients with Acromegaly Returns Elevated Markers of Bone Turnover to Normal J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5650 - 5655. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Gravholt, A. L. Lauridsen, K. Brixen, L. Mosekilde, L. Heickendorff, and J. S. Christiansen Marked Disproportionality in Bone Size and Mineral, and Distinct Abnormalities in Bone Markers and Calcitropic Hormones in Adult Turner Syndrome: A Cross-Sectional Study J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2798 - 2808. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Smith, M. E. Wastney, B. V. Morukov, I. M. Larina, L. E. Nyquist, S. A. Abrams, E. N. Taran, C.-Y. Shih, J. L. Nillen, J. E. Davis-Street, et al. Calcium metabolism before, during, and after a 3-mo spaceflight: kinetic and biochemical changes Am J Physiol Regulatory Integrative Comp Physiol, July 1, 1999; 277(1): R1 - R10. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Broyles, R. G. Nielsen, E. M. Bussett, W. D. Lu, I. A. Mizrahi, P. A. Nunnelly, T. A. Ngo, J. Noell, R. H. Christenson, and B. C. Kress Analytical and clinical performance characteristics of Tandem-MP Ostase, a new immunoassay for serum bone alkaline phosphatase Clin. Chem., October 1, 1998; 44(10): 2139 - 2147. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |